Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States.

Naidu, Srihari S; Sutton, Megan B; Gao, Wei; Fine, Jennifer T; Xie, Jipan; Desai, Nihar R; Owens, Anjali T

Naidu, Srihari S; Sutton, Megan B; Gao, Wei; Fine, Jennifer T; Xie, Jipan; Desai, Nihar R; Owens, Anjali T.

Affiliation

Naidu SS; Westchester Medical Center, Westchester Medical Center Health Network, Valhalla, NY, USA.
Sutton MB; New York Medical College, Valhalla, NY, USA.
Gao W; MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, CA, USA.
Fine JT; Analysis Group, Inc., Boston, MA, USA.
Xie J; MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, CA, USA.
Desai NR; Analysis Group, Inc., Los Angeles, CA, USA.
Owens AT; Yale University School of Medicine, New Haven, CT, USA.

J Med Econ ; 26(1): 682-690, 2023.

Article de En | MEDLINE | ID: mdl-37170479

Sujet(s)
Mots clés

Hypertrophic cardiomyopathy; I; I1; I10; I12; clinical burden; diagnostic history; economic burden; real-world evidence

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cardiomyopathie hypertrophique / Medicare (USA) Type d'étude: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Humans Pays/Région comme sujet: America do norte Langue: En Journal: J Med Econ Sujet du journal: SERVICOS DE SAUDE Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google